Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association
As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …
Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review
Abstract Evaluation of coronary artery disease (CAD) using coronary computed tomography
angiography (CCTA) has seen a paradigm shift in the last decade. Evidence increasingly …
angiography (CCTA) has seen a paradigm shift in the last decade. Evidence increasingly …
[HTML][HTML] Pitavastatin to prevent cardiovascular disease in HIV infection
SK Grinspoon, KV Fitch, MV Zanni… - … England Journal of …, 2023 - Mass Medical Soc
Background The risk of cardiovascular disease is increased among persons with human
immunodeficiency virus (HIV) infection, so data regarding primary prevention strategies in …
immunodeficiency virus (HIV) infection, so data regarding primary prevention strategies in …
PET/MR imaging of inflammation in atherosclerosis
Myocardial infarction, stroke, mental disorders, neurodegenerative processes, autoimmune
diseases, cancer and the human immunodeficiency virus impact the haematopoietic system …
diseases, cancer and the human immunodeficiency virus impact the haematopoietic system …
HIV-1–associated atherosclerosis: unraveling the missing link
Cardiovascular disease, including atherosclerosis and atherosclerosis-associated
complications, is an increasing cause of morbidity and mortality in human immunodeficiency …
complications, is an increasing cause of morbidity and mortality in human immunodeficiency …
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
SK Grinspoon, KV Fitch, ET Overton… - American heart …, 2019 - Elsevier
Background Cardiovascular disease (CVD) is more frequent among people with HIV (PWH)
and may relate to traditional and nontraditional factors, including inflammation and immune …
and may relate to traditional and nontraditional factors, including inflammation and immune …
Interactions of HIV and antiretroviral therapy with neutrophils and platelets
M Madzime, TM Rossouw, AJ Theron… - Frontiers in …, 2021 - frontiersin.org
Neutrophils are important components of the innate immune system that mediate pathogen
defense by multiple processes including phagocytosis, release of proteolytic enzymes …
defense by multiple processes including phagocytosis, release of proteolytic enzymes …
Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure
RM Alvi, AM Neilan, N Tariq, M Awadalla… - Journal of the American …, 2018 - jacc.org
Background: Incident heart failure (HF) is increased in persons with human
immunodeficiency virus (PHIV). Protease inhibitors (PIs) are associated with adverse …
immunodeficiency virus (PHIV). Protease inhibitors (PIs) are associated with adverse …
HIV-associated cardiovascular disease pathogenesis: an emerging understanding through imaging and immunology
Cardiac abnormalities were identified early in the epidemic of AIDS, predating the isolation
and characterization of the etiologic agent, HIV. Several decades later, the causation and …
and characterization of the etiologic agent, HIV. Several decades later, the causation and …
Association of HIV infection with cardiovascular pathology based on advanced cardiovascular imaging: a systematic review
Importance HIV-associated cardiovascular disease is increasing in prevalence, but its
mechanisms remain poorly understood. Objective To systematically review data from …
mechanisms remain poorly understood. Objective To systematically review data from …